Medpace Holdings, Inc. (BMV:MEDP)

Market Cap	168.31B
Revenue (ttm)	44.08B
Net Income (ttm)	8.51B
Shares Out	n/a
EPS (ttm)	267.54
PE Ratio	19.78
Forward PE	24.08
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12
Average Volume	323
Open	5,880.00
Previous Close	n/a
Day's Range	5,880.00 - 5,880.00
52-Week Range	5,764.00 - 7,655.00
Beta	n/a
RSI	56.43
Earnings Date	Jul 21, 2025

About Medpace Holdings

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigi...

• Industry: Commercial Physical and Biological Research
• Founded: 1992
• Employees: 5,900
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: MEDP

Financial Performance

In 2024, Medpace Holdings's revenue was $2.11 billion, an increase of 11.84% compared to the previous year's $1.89 billion. Earnings were $404.34 million, an increase of 43.07%.

Financial numbers in USD